Skip to main content
Cureus logoLink to Cureus
. 2022 May 24;14(5):e25279. doi: 10.7759/cureus.25279

Boerhaave Syndrome: An Unexpected Complication of Diabetic Ketoacidosis

Brandon Wiggins 1,, Fady Banno 1, Kyle T Knight 1, Ian Fladie 2, Justin Miller 3
Editors: Alexander Muacevic, John R Adler
PMCID: PMC9224768  PMID: 35755500

Abstract

Boerhaave syndrome (BS) is a rare gastrointestinal condition related to esophageal rupture that carries a high mortality rate without prompt medical attention. BS is commonly associated with repeated episodes of severe retching, straining, or vomiting. Diabetic ketoacidosis (DKA), a serious acute complication of diabetes, is characterized in part by laboratory findings of profound hyperglycemia and ketoacidosis. Clinically, nausea and vomiting are seen commonly in DKA patients, which can often include repeated forceful retching, but rarely associated with esophageal rupture. In this article, we will describe a case of BS secondary to repeated episodes of emesis in the setting of DKA.

Keywords: type 2 diabetes mellitus, esophagus rupture, diabetic ketoacidosis (dka), complications of dka, boerhaave’s syndrome

Introduction

Boerhaave syndrome (BS) can be characterized by full-thickness esophageal perforation induced by barogenic trauma [1]. The mechanism for barogenic trauma involves repeat pyloric closure with subsequent diaphragmatic contraction against a closed cricopharyngeus [1]. Repeated increase of intra-esophageal pressure can then result in esophageal perforation [2,3]. Esophageal perforation in BS occurs in the left posterolateral aspect of the distal intrathoracic esophagus in 90% of patients. However, rupture of the cervical and intra-abdominal esophagus may also occur [1,4]. Rupture of the esophagus is subsequently followed by contamination of the mediastinum and pleural cavities by gastric contents; mechanical movement of the chest during respiration will dissipate these substances, leading to greater mediastinal and pleural soilage [1]. In the absence of medical and surgical intervention, bacterial infection and mediastinal necrosis will result, eventually leading to sepsis and multiple organ dysfunction syndrome [4,5].

BS in the setting of diabetic ketoacidosis (DKA) has been previously reported in the medical literature, albeit exceedingly rare. Upon review of available literature, two prior case reports describe such a situation. In one of these, a 2013 report by Alkuja et al., an iatrogenic etiology of esophageal rupture could not be ruled out [6,7].

Case presentation

An otherwise healthy 22-year-old male presented to the emergency department due to nausea, vomiting, abdominal pain, and chest pain for the previous four days with associated fatigue and polyuria. Emesis was noted to be non-bilious, non-bloody but seemingly constant. The patient reported that he could not tolerate anything by mouth during this time. The chest pain was described as substernal, non-radiating, constant, progressively worsening, and provoked by eating. The abdominal pain was described as diffuse, non-radiating, constant, stabbing in nature, and provoked by eating.

Vital signs on arrival at the emergency department were significant for a heart rate of 108 beats per minute and a respiratory rate of 25 breaths per minute. Physical examination was remarkable for a lethargic male that appeared his stated age with tachypnea, tachycardia, and a diffusely tender abdomen in all four quadrants. Chest X-ray on presentation was read as a normal exam. Laboratory studies demonstrated glucose of 1347 mg/dL, anion gap of 50 mmol/L, and a white blood cell count of 26.3 k/cm2. Venous blood gas (VBG) revealed a pH of 7.149, pCO2 of 26 mmHg, and bicarbonate of 8.7 mmol/L, consistent with metabolic acidosis. Urinalysis (UA) showed 3+ glucose and 2+ ketones. Beta-hydroxybutyrate was over 8 mmol/L. Combined results of the VBG, UA, and comprehensive blood profile indicated that the patient was in DKA (Table 1). The patient was started on an intravenous (IV) insulin infusion and IV fluids and transferred to the intensive care unit. 

Table 1. Laboratory results on presentation.

Laboratory Values Measured Normal Range
White Blood Cell Count 26.3 k/cm2 4.5-11 k/cm2
Hemoglobin 15.4 g/dL 11-16.2 g/dL
Hematocrit 50.6% 36-46%
Platelet Count 358 k/cm2 140-440 k/cm2
Serum Sodium Level 118 mmol/L 136-144 mmol/L
Serum Potassium Level 7 mmol/L 3.6-5.1 mmol/L
Serum Chloride Level 61 mmol/L 101-111 mmol/L
Total Serum Carbon Dioxide 7 mmol/L 20-30 mmol/L
Serum Blood Urea Nitrogen 59 mg/dL 8-26 mg/dL
Serum Creatinine Level 4.43 mg/dL 0.44-1.00 mg/dL
Anion Gap 50 mmol/L 8-16 mmol/L
Serum Glucose 1347 mg/dL 70-99 mg/dL
Serum Calcium Level 8.3 mg/dL 8.4-10.2 mg/dL
Serum Magnesium Level 3.6 mg/dL 1.6-2.6 mg/dL
Serum Phosphorus Level 14.9 mg/dL 2.3-4.7 mg/dL
Total Bilirubin 0.5 mg/dL 0.3-1 mg/dL
Serum Albumin Level 4.8 g/dL 3.5-5 g/dL
Aspartate Aminotransferase 8 U/L 15-41 U/L
Alanine Aminotransferase 18 U/L 14-54 U/L
Serum Alkaline Phosphatase 173 U/L 41-150 U/L
Beta Hydroxybutyrate >8 mmol/L 0-0.3 mmol/L
Venous Blood Gas pH 7.149 7.32-7.42
Venous Blood Gas pCO2 26 mmHg 41-51 mmHg
Venous Blood Gas pO2 64 mmHg 37-43 mmHg
Venous Blood Gas Bicarbonate 8.7 mmol/L 23-29 mmol/L

After transfer, the patient continued to complain of constant chest pain that was pleuritic. Computed tomography (CT) of the chest, abdomen, and pelvis with contrast was ordered due to concern for non-specific pain and demonstrated anterior and posterior pneumomediastinum with diffuse thickening of the distal esophagus, confirming esophageal perforation consistent with BS (Figures 1, 2). The patient was then transferred to a tertiary care facility with a dedicated cardiothoracic surgeon on call and lost to follow-up thereafter.

Figure 1. Transverse-view computed tomography of the chest in abdomen window.

Figure 1

Red arrow demonstrates thickening of the distal esophagus with perforation consistent with Boerhaave syndrome. Yellow arrow demonstrates pneumomediastinum secondary to esophageal perforation.

Figure 2. Transverse-view computed tomography of the chest in lung window.

Figure 2

Red arrow demonstrates esophageal thickening and perforation secondary to Boerhaave syndrome.

Discussion

BS remains a feared complication secondary to sudden increased intra-esophageal pressure from retching with subsequent esophageal perforation. BS has an incidence rate of 3.1 per million and is fatal if left untreated [8]. BS typically is seen in middle-aged men between the ages of 50 and 70 and alcohol is usually involved [8].

BS usually occurs in patients without underlying esophageal disease. However, a subset of patients has esophageal rupture secondary to peptic ulcers, Barrett esophagus, eosinophilic esophagitis, pill esophagitis, and other causes of esophageal inflammation [2,3,8]. DKA has been associated with nausea, vomiting, and Mallory-Weiss tears in the extreme, but is seldomly associated with BS. BS typically is caused by a sudden increase in intra-esophageal pressure with an associated increase in intrathoracic pressure. Leakage of esophageal contents may cause chemical mediastinitis, predisposing patients to further complications including infection, mediastinal necrosis, pneumomediastinum, and end-organ damage [5].

Signs of BS vary widely based on the anatomical location of the rupture. Most commonly, patients present with refractory, unremitting chest pain, crepitus on palpation, fever, dyspnea, tachycardia, tachypnea, cyanosis, and hypotension [2]. More proximal ruptures can present with neck pain, dysphagia, or dysphonia [9].

BS is usually diagnosed incidentally in patients being evaluated for chest pain. It should be suspected in patients who complain of severe neck, chest, or upper abdominal pain after an episode of severe retching and vomiting. Other causes of increased intrathoracic pressure such as intubation, pneumothorax, and pleural effusions may also result in BS. Subcutaneous emphysema may be noted on physical examination and the diagnosis is established by CT scan with oral contrast. Delay in diagnosis is often associated with a higher risk of mortality and complications [10]. 

Myocardial infarction, pancreatitis, aortic aneurysm, peptic ulcer disease, pneumonia, or spontaneous pneumothorax can also cause acute-onset chest or upper abdominal pain. History, electrocardiogram, laboratory evaluation (e.g., cardiac biomarkers, D-dimer, pancreatic enzymes), diagnostic imaging (e.g. chest X-ray, abdominal ultrasound, CT chest/abdomen/pelvis), and physical examination are important to distinguish these etiologies from esophageal perforation. In addition, patients with Mallory-Weiss syndrome may have similar, albeit less severe presentation; however, there will be no evidence of subcutaneous, mediastinal, or peritoneal air on radiography or extravasation of esophageal contrast [11].

Perforations diagnosed within 12-24 hours have the best outcomes. There are three common treatment options including conservative, endoscopic, and surgical. Intensive care unit admission is recommended not only for patients with hemodynamic instability but also for patients with multiple comorbid conditions [12]. Additionally, all patients with esophageal perforation should avoid oral intake or nasogastric tube placement. IV broad-spectrum antibiotics, proton-pump inhibitors, and antiemetics should be initiated, and nutrition should typically be parenteral. Surgical consultation is warranted for all patients in case of further deterioration after medical or endoscopic management. 

Endoscopic management of esophageal perforation should be considered in patients who are not surgical candidates or with extensive underlying comorbidities [13-15]. A multidisciplinary team of endoscopists and thoracic surgeons may work together to deploy fully covered esophageal stents, through-the-scope clips, over-the-scope clips, endoscopic suturing, or esophageal resection and diversion.

The prognosis usually depends on the timing of diagnosis and treatment. Delayed diagnosis and treatment are usually associated with poor outcomes. Those who undergo diagnosis and surgery within 24 hours carry a survival rate of approximately 75%, but this can drop to 50% if the diagnosis and treatment are delayed after 24 hours and approximately 10% after 48 hours [16].

Conclusions

BS related to DKA has rarely been described in medical literature in the past. With this rare association in mind, clinicians should add BS to the differential when faced with patients experiencing extreme chest pain in DKA. The severe retching seen in DKA typically manifests with Mallory-Weiss tears in the extremis, but BS has also been identified as a possible, albeit rare, complication discussed in the above case. This case was unique in the sense that many patients have severe retching during DKA but do not develop BS. Our patient also did not fit the typical demographic that develops BS other than being male, as he was not middle-aged or using alcohol.

In this case, we highlight the importance of radiologic imaging acquisition in a timely manner to provide a diagnosis for extreme chest pain in the setting of DKA. Also highlighted is the benefit of using CT chest and abdomen in DKA cases that present with chest pain and abdominal pain to rule in BS. Prompt CT will allow for appropriate surgical or endoscopic care quickly to prevent high morbidity and mortality associated with delay. We hope this case provides awareness to clinicians of BS as part of the differential diagnosis in patients with severe chest and abdominal pain after retching.

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

The authors have declared that no competing interests exist.

Human Ethics

Consent was obtained or waived by all participants in this study

References

  • 1.Boerhaave's syndrome: diagnosis and surgical management. Khan AZ, Strauss D, Mason RC. Surgeon. 2007;5:39–44. doi: 10.1016/s1479-666x(07)80110-7. [DOI] [PubMed] [Google Scholar]
  • 2.Spontaneous rupture of the esophagus: a 30-year experience. Pate JW, Walker WA, Cole FH Jr, Owen EW, Johnson WH. Ann Thorac Surg. 1989;47:689–692. doi: 10.1016/0003-4975(89)90119-7. [DOI] [PubMed] [Google Scholar]
  • 3.Eponyms in esophageal surgery, part 2. Herbella FA, Matone J, Del Grande JC. Dis Esophagus. 2005;18:4–16. doi: 10.1111/j.1442-2050.2005.00447.x. [DOI] [PubMed] [Google Scholar]
  • 4.Atypical presentation of Boerhaave's syndrome as Enterococcal bacterial pericardial effusion. Saha A, Jarvis M, Thorpe JA, O'Regan DJ. Interact Cardiovasc Thorac Surg. 2007;6:130–132. doi: 10.1510/icvts.2006.139667. [DOI] [PubMed] [Google Scholar]
  • 5.Operative and nonoperative management of esophageal perforations. Michel L, Grillo HC, Malt RA. Ann Surg. 1981;194:57–63. doi: 10.1097/00000658-198107000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Pneumomediastinum complicating diabetic ketoacidosis and Boerhaave's syndrome. Alkhuja S, Gazizov N, Charles G. Case Rep Med. 2013;2013:598720. doi: 10.1155/2013/598720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Boerhaave syndrome presenting as tension pneumothorax: first reported North American case. Vallabhajosyula S, Sundaragiri PR, Berim IG. J Intensive Care Med. 2016;31:349–352. doi: 10.1177/0885066615606698. [DOI] [PubMed] [Google Scholar]
  • 8.Evolving options in the management of esophageal perforation. Brinster CJ, Singhal S, Lee L, Marshall MB, Kaiser LR, Kucharczuk JC. Ann Thorac Surg. 2004;77:1475–1483. doi: 10.1016/j.athoracsur.2003.08.037. [DOI] [PubMed] [Google Scholar]
  • 9.Boerhaave's syndrome: analysis of the literature and report of 18 new cases. Brauer RB, Liebermann-Meffert D, Stein HJ, Bartels H, Siewert JR. Dis Esophagus. 1997;10:64–68. doi: 10.1093/dote/10.1.64. [DOI] [PubMed] [Google Scholar]
  • 10.Perforation and rupture of the esophagus. Larsen K, Skov Jensen B, Axelsen F. Scand J Thorac Cardiovasc Surg. 1983;17:311–316. doi: 10.3109/14017438309099370. [DOI] [PubMed] [Google Scholar]
  • 11.Life-threatening acute posterior mediastinitis due to esophageal perforation. Burnett CM, Rosemurgy AS, Pfeiffer EA. Ann Thorac Surg. 1990;49:979–983. doi: 10.1016/0003-4975(90)90882-7. [DOI] [PubMed] [Google Scholar]
  • 12.Management of esophageal perforation in 120 consecutive patients: clinical impact of a structured treatment algorithm. Lindenmann J, Matzi V, Neuboeck N, Anegg U, Maier A, Smolle J, Smolle-Juettner FM. J Gastrointest Surg. 2013;17:1036–1043. doi: 10.1007/s11605-012-2070-8. [DOI] [PubMed] [Google Scholar]
  • 13.Endoscopic stent insertion versus primary operative management for spontaneous rupture of the esophagus (Boerhaave syndrome): an international study comparing the outcome. Schweigert M, Beattie R, Solymosi N, et al. Am Surg. 2013;79:634–640. doi: 10.1177/000313481307900627. [DOI] [PubMed] [Google Scholar]
  • 14.Primary and rescue endoluminal vacuum therapy in the management of esophageal perforations and leaks. Still S, Mencio M, Ontiveros E, Burdick J, Leeds SG. Ann Thorac Cardiovasc Surg. 2018;24:173–179. doi: 10.5761/atcs.oa.17-00107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Role of endoscopy in the management of Boerhaave syndrome. Tellechea JI, Gonzalez JM, Miranda-García P, Culetto A, D'Journo XB, Thomas PA, Barthet M. Clin Endosc. 2018;51:186–191. doi: 10.5946/ce.2017.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.A case of Boerhaave's syndrome associated with raised intraocular pressure. Nabili S, Murdoch JR. Br J Ophthalmol. 2003;87:650–651. doi: 10.1136/bjo.87.5.650. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES